Public Market Listing
068270KOSPI
Live quotes, historical charts, and market capitalization for Celltrion are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(14 total)
14Total Assets
9Approved
5Phase 3 / Filed
0Phase 1–2 / Early
8Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | TNF-alpha | Inflammatory Bowel DiseasePsoriatic Arthritis Ulcerative Colitis, Crohn's Disease | |
Aflibercept(Eylea) | Approved | VEGF-A · VEGF-A / VEGF-B / Placental Growth Factor (PlGF)Protein / enzyme therapeutic | Age-Related Macular Degeneration |
CT-P13(Inflectra / Remsima) | Approved | TNF-alphaMonoclonal antibody | Inflammatory Bowel DiseaseRheumatoid Arthritis Ulcerative Colitis, Crohn's Disease |
CT-P47 (tocilizumab)(Avtozma) | Approved | IL-6R antagonistMonoclonal antibody | Rheumatoid Arthritis |
infliximab(Remicade) | Approved | TNF-alphaMonoclonal antibody | Inflammatory Bowel DiseasePsoriatic ArthritisPsoriasisRheumatoid Arthritis Ulcerative Colitis, Crohn's Disease |
| Approved | TNF-alpha | Inflammatory Bowel DiseasePsoriatic Arthritis Ulcerative Colitis, Crohn's Disease | |
| Approved | TNF-alpha | Inflammatory Bowel Disease Ulcerative Colitis, Crohn's Disease | |
| Approved | IL-23 p19 · IL-12 p40 | Inflammatory Bowel DiseasePsoriatic Arthritis Ulcerative Colitis, Crohn's Disease | |
| Approved | VEGF-AMonoclonal antibody | Non-Small Cell Lung Cancer | |
CT-P10No recent activity | Phase 3 | CD20Monoclonal antibody | Rheumatoid Arthritis |
| Phase 3 | TNF-alphaMonoclonal antibody | Rheumatoid Arthritis | |
| Phase 3 | CD38Monoclonal antibody | Multiple Myeloma | |
| Phase 3 | PD-1Small molecule | Non-Small Cell Lung Cancer | |
| Phase 3 | CD20Monoclonal antibody | Multiple Sclerosis |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.